DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Spinal Cord Stimulation Devices Market 2016-2020" report to their offering.
The global spinal cord stimulation (SCS) devices market to grow at a CAGR of 4.84% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global spinal cord stimulation (SCS) devices market for 2016-2020. To calculate the market size, we consider the revenue generated from the sale of SCS devices. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Shift of surgeons' focus toward SCS procedures will be a key trend for market growth. Surgeons prefer MIS compared with open surgery as it is considered to be safe and allows patients to recover faster. They have fewer scars on the operated area and the surgery is not less painful compared with the other surgeries. MIS is usually carried out in outpatient settings and requires only a short hospital stay.
MIS has gained huge acceptance as it reduces the operative traumatic stress without compromising on therapeutic benefits. The latest robotic-assisted technique requires incisions of a few millimeters in length, as well as highly skilled surgeons. The use of MIS techniques to treat spine-related disorders is likely to increase in the coming years.
According to the report, one of the key drivers for market growth will be rapid advances in high-frequency device technologies leading to rise in implantation procedures. Manufacturers are spending heavily on research to increase the efficiency of SCS devices and develop innovative products for improved patient care. The older versions of devices with battery life of 3-5 years are being replaced with the latest rechargeable devices, which have a battery life of 15-20 years.
These new advanced devices can be used in future for indications related to chronic, intractable pain of the trunk and limbs. The upcoming devices are much more refined, upgraded, and tailor-made in contrast to the currently used SCS devices that have procedural invasiveness, weigh more, and are ineffective in pain relief over time.
Key vendors
- Boston Scientific
- Medtronic
- Nevro
- St. Jude Medical
Other prominent vendors
- Greatbatch
- Stimwave
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by application
Part 07: Market segmentation by product
Part 08: Market segmentation by end-user
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/x35kkc/global_spinal
